Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
Policy & Regulation · page 4
- Cultivation
‘No Right to GMP Washing’: German State Challenges Cannabis Flower Import Compliance
Authorities from the German state of Hesse have taken aim at the practice of ‘GMP washing’ in its thriving medical cannabis market, an intervention that could have significant implications for the industry at large.
- Cultivation
EU Medical Cannabis Faces Its Most Consequential Regulatory Overhaul
Cultivation is perhaps the most complex, highly regulated, and expensive part of the cannabis supply chain.
- Medical Cannabis
France Breaks Medical Cannabis Deadlock as Reimbursement Decree Filed for Legal Review
France’s incoming generalised medical cannabis framework has edged tantalisingly close to clearing its last remaining hurdle, as the outstanding decree governing the reimbursement of cannabis medicines has been submitted to France’s highest administrative court.
- US & Canada
DEA Opens Rescheduling Hearing With Science-Based Support for Its Own Rule
On Monday (June 29), the most consequential hearing in the history of US cannabis policy began proceedings, as the DEA and the seven invited representatives made their opening statements.
- UK & Europe
Ireland’s Cross-Party Drug Committee Calls for Full Decriminalisation. The Government Has Already Said No
Ireland’s Oireachtas Joint Committee on Drugs Use has recommended the full decriminalisation of personal possession of all drugs, calling on the government to repeal Section 3 of the Misuse of Drugs Act 1977.
- US & Canada
‘A Giant Ship With a Rusty Rudder’: What Six Weeks of Cannabis Rescheduling Has and Hasn’t Changed
On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA Administrative Law Judge (ALJ) hearing that could determine whether adult-use cannabis joins state-licensed medical cannabis on Schedule III of the Controlled Substances Act, begins proceedings.
- International Regulation
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
Thirteen years ago, Uruguay became the first country on the planet to officially legalise cannabis for recreational (adult-use) purposes.
- Hemp Industry
Is the US Hemp Ban Punishing the Wrong People?
This article was written for Business of Cannabis by Scott Mazza, Co-Founder of Vitality CBD and Certified Headies Uncertainty isn’t what hemp needs right now.
- US & Canada
DEA Selects Only Cannabis Opponents For Crucial June 29 Rescheduling Hearing
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have wasted no time in capitalising on the historic reclassification.
- Medical Cannabis
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows Opioid Reductions
France’s health minister has confirmed to Agence France-Presse (AFP) that the delayed regulatory texts needed to push through its incoming generalised medical cannabis market will be published next month (July 2026).
- US & Canada
Mounting Legal Challenges Threaten Hearing to Extend Cannabis Rescheduling to Adult Use
The critical June 29 administrative hearing, set to determine whether the US will extend rescheduling efforts to recreational cannabis, is now set to be a fiercely contested event.
- International Regulation
Stop Consulting, Start Implementing: South Africa’s Cannabis Industry Demands Action as Businesses Suffer
South Africa’s long-suffering cannabis operators have demanded that the government make good on its extensive plans for a regulated framework, as frustration with its lack of meaningful action reaches a boiling point.
